ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

NCI Advisory Group, Other Cancer Meetings

February 22, 1985

In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS

July 3, 1987

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

S-1 After Surgery Improves Survival, Japanese Trial Finds

February 23, 2007